The first successful
targeted human gene therapy was reported in 2000.
Not exact matches
Before moving on to
human trials, they will need to study all instances of «off -
target» effects: Years before Crispr, the viruses employed to deliver DNA in
gene therapy trials occasionally damaged the whole system, causing cancer.
In
humans, variants of the IL - 15R - alpha
gene have been found in world - class endurance competitors, suggesting a
target for
gene therapies aimed at boosting the ability to exercise longer.
This is a great example of a potential
gene therapy target that still needs a fair amount of work to validate the thesis and the initial data, but having a large number of existing
human carriers is a good sign on the safety front.